IARC classifications - National Cancer Control Policy

    IARC classifications

    From National Cancer Control Policy


    The International Agency for Research on Cancer (IARC) have devised a system of categories to evaluate the carcinogenicity of an agent to humans[1]. An agent is classified based on scientific evidence derived from human and experimental animal studies and from mechanistic and other relevant data[2]. The list of categories and their definition are shown in Table 1.

    Table 1. IARC classifications of carcinogenic agents[1][2]

    Group Description Definition Number of agents
    Group 1 Carcinogenic to humans
    • Sufficient evidence of carcinogenicity OR
    • Evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent acts through a relevant mechanism of carcinogenicity
    121
    Group 2A Probably carcinogenic to humans*
    • Limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals OR
    • Inadequate evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals and strong evidence that the carcinogenesis is mediated by a mechanism that also operates in humans OR
    • Limited evidence of carcinogenicity in humans, but belongs, based on mechanistic considerations, to a class of agents for which one or more members have been classified in Group 1 or Group 2A
    89
    Group 2B Possibly carcinogenic to humans*
    • Limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals OR
    • Inadequate evidence of carcinogenicity in humans but sufficient evidence of carcinogenicity in experimental animals OR
    • Inadequate evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals, but with supporting evidence from mechanistic and other relevant data
    318
    Group 3 Not classifiable as to its carcinogenicity to humans
    • Evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals OR
    • Evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals, but strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans OR
    • Agents that do not fall into any other group


    Agents in Group 3 are not determined to be non-carcinogenic or safe overall, but often means that further research is needed.

    499

    * The terms probably carcinogenic and possibly carcinogenic have no quantitative significance and are used simply as descriptors of different levels of evidence of human carcinogenicity, with probably carcinogenic signifying a higher level of evidence than possibly carcinogenic.

    References

    1. 1.0 1.1 International Agency for Research on Cancer. Agents classified by the IARC monographs, volumes 1–129. [homepage on the internet] Lyon: IARC; [cited 2021 May 19; updated 2021 Mar 26]. Available from: http://monographs.iarc.fr/ENG/Classification/index.php.
    2. 2.0 2.1 International Agency for Research on Cancer. Preamble to the IARC monographs - scientific review and evaluation. [homepage on the internet] Lyon: IARC; 2006 Jan 23 [cited 2013 Oct 21; updated 2013 Oct 21]. Available from: http://monographs.iarc.fr/ENG/Preamble/currentb6evalrationale0706.php.

    Back to top

    Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.